Replies to post #5198 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>GTC anticipates… completing the rolling submission after all clinical data is gathered, analyzed, and available for the BLA, which is planned by end 1Q08.<

This guidance is out of date as can be seen in the chart in #msg-23625770. Regards, Dew